World's Best Scientists 2026 revealed!
Tobias R. Kollmann

Tobias R. Kollmann

D-Index & Metrics

Immunology

D-Index
62
Citations
14294
World Ranking
3136
National Ranking
76

Tobias R. Kollmann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tobias R. Kollmann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tobias R. Kollmann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tobias R. Kollmann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tobias R. Kollmann is affiliated with Dalhousie University in Canada and has a primary research focus in medicine, with significant contributions to immunology and microbiology. Their work spans various subfields, including immunology, infectious diseases, epidemiology, molecular biology, and health.

The scientist's research encompasses several main topics, particularly relating to immune responses and vaccinations, vaccine coverage and hesitancy, and COVID-19 clinical and reproductive impacts. They have also worked on neonatal respiratory health research and diabetes-related disorders.

Representative recent papers include:

  • Immunological mechanisms of vaccine-induced protection against COVID-19 in humans, 2021, Nature reviews. Immunology
  • Interferon-α2b Treatment for COVID-19, 2020, Frontiers in Immunology
  • Lactiplantibacillus plantarum-Nomad and Ideal Probiotic, 2021, Frontiers in Microbiology
  • Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?, 2020, Trends in Immunology
  • The non-specific and sex-differential effects of vaccines, 2020, Nature reviews. Immunology

Kollmann collaborates frequently with several researchers, including Nelly Amenyogbe, Rym Ben-Othman, Casey P. Shannon, Scott J. Tebbutt, and Beate Kampmann. These co-authors have partnered on multiple research projects, indicating sustained collaborative efforts.

The scientist regularly publishes in key venues related to their fields of study. The most frequent publication outlets are Frontiers in Immunology, Vaccine, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Infectious Diseases, and Journal of Molecular Biology.

In addition to journal articles, Kollmann has contributed to book publications. Notably, one book published by Frontiers Media is titled Impact of Microbiome on Gut Mucosal Immunity in Health and Disease (2022).

Best Publications

  • Early infancy microbial and metabolic alterations affect risk of childhood asthma

    Marie-Claire Arrieta;Leah T. Stiemsma;Pedro A. Dimitriu;Lisa Thorson

  • Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly

    Tobias R. Kollmann;Ofer Levy;Ruth R. Montgomery;Stanislas Goriely

  • Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.

    Manish Sadarangani;Arnaud Marchant;Tobias R. Kollmann

  • Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults

    Tobias R. Kollmann;Juliet Crabtree;Annie Rein-Weston;Darren Blimkie

  • Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

    Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar

  • Interferon-α2b Treatment for COVID-19

    Qiong Zhou;Virginia Chen;Casey P. Shannon;Xiao Shan Wei

  • Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny

    Tobias R. Kollmann;Beate Kampmann;Sarkis K. Mazmanian;Arnaud Marchant

  • Harnessing the beneficial heterologous effects of vaccination

    Helen S. Goodridge;S. Sohail Ahmed;Nigel Curtis;Tobias R. Kollmann

  • The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma

    Padmaja Subbarao;Sonia S Anand;Allan B Becker;A Dean Befus

  • The Role of Environmental Factors in Modulating Immune Responses in Early Life

    Duncan Malcolm MacGillivray;Tobias R Kollmann

  • Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells

    Nathan P. Corbett;Darren Blimkie;Kevin C. Ho;Bing Cai

  • Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity

    Sing Sing Way;Lucas J. Thompson;Jared E. Lopes;Adeline M. Hajjar

  • Maternal immunisation: collaborating with mother nature.

    Arnaud Marchant;Manish Sadarangani;Manish Sadarangani;Mathieu Garand;Mathieu Garand;Nicolas Dauby

  • Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study.

    Maxwell M. Tran;Diana L. Lefebvre;Christoffer Dharma;David Dai

  • Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections

    Nicolas Dauby;Tessa Goetghebuer;Tobias R Kollmann;Jack Levy

  • Dynamic molecular changes during the first week of human life follow a robust developmental trajectory.

    Ahwon Lee;Casey P Shannon;Nelly Amenyogbe;Nelly Amenyogbe;Tue Tb Bennike;Tue Tb Bennike

  • HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.

    Amy Slogrove;Amy Slogrove;Brian Reikie;Shalena Naidoo;Corena De Beer

  • Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.

    Peter Aaby;Tobias R Kollmann;Christine Stabell Benn

  • Modes of Infant Feeding and the Risk of Childhood Asthma: A Prospective Birth Cohort Study.

    Annika Klopp;Lorena Vehling;Allan B. Becker;Padmaja Subbarao

  • Development of immunity in early life

    Anu Goenka;Tobias R. Kollmann

  • GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults

    Hayedeh Behzad;Anke L. W. Huckriede;Laura Haynes;Beth Gentleman

Frequent Co-Authors

Ofer Levy
Ofer Levy Boston Children's Hospital
Stuart E. Turvey
Stuart E. Turvey University of British Columbia
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Malcolm R. Sears
Malcolm R. Sears McMaster University
William W. Mohn
William W. Mohn University of British Columbia
Allan B. Becker
Allan B. Becker University of Manitoba
Christopher B. Wilson
Christopher B. Wilson Bill & Melinda Gates Foundation
David P. Speert
David P. Speert University of British Columbia
Mel Krajden
Mel Krajden University of British Columbia
Michael S. Kobor
Michael S. Kobor University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare professions, many of which offer flexible online degree options. For those without a nursing background interested in healthcare, online ABSN programs for non nurses provide an accelerated pathway into nursing. These programs balance rigorous training with accessibility, making a nursing career more attainable.

If gaining admission feels daunting, exploring ABSN programs with high acceptance rates can increase your chances of enrollment without compromising quality education. These programs tend to focus on comprehensive support and streamlined admissions processes.

For those aiming at practical nursing roles, considering the fastest and easiest LPN programs might be ideal. They offer a quick entry into nursing careers through shorter and more accessible curriculums while still meeting licensure requirements.

Advanced practice nurses can explore easiest NP programs to get into, which provide essential skills and expertise to work in specialized healthcare fields, including immunology research and patient care. Selecting the right program based on entry criteria and career goals can significantly impact your professional journey.

Best Scientists Citing Tobias R. Kollmann

Trending Scientists